Diversified Consumer Services
Company Overview of Johns Hopkins School of Medicine
Johns Hopkins School of Medicine is an educational institution that offers training in medical disciplines. It offers doctorate programs for Medicinae Doctor (M.D.) and Philosophiae Doctor (Ph. D.). In addition, it offers a biomedical engineering program. The school provides education in medical disciplines such as Anesthesiology and Critical Care Medicine, Biological Chemistry, Cell Biology, Emergency Medicine, Neuroscience, Oncology, Orthopedic Surgery, Pathology, Pediatrics, Physiology, Radiology, Surgery, and Urology. Johns Hopkins School of Medicine is based in Baltimore, Maryland. The School of Medicine is a subsidiary of the Johns Hopkins University.
720 Rutland Avenue
Baltimore, MD 21205-2196
Key Executives for Johns Hopkins School of Medicine
Compensation as of Fiscal Year 2014.
Johns Hopkins School of Medicine Key Developments
Compugen Ltd. Announces Initiation of Multi-Year Research Collaboration with Johns Hopkins School of Medicine
Dec 18 14
Compugen Ltd. announced the initiation of a multi-year research collaboration with Johns Hopkins University, School of Medicine, on evaluating immune checkpoint candidates. The project will be directed by Prof. Drew Pardoll and Dr. Charles Drake of John Hopkins. Prof. Pardoll and Dr. Drake, members of Compugen's Scientific Advisory Board, are pioneers in the field of immuno-oncology. The collaboration will focus on further evaluation of selected novel B7/CD28-like immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. This evaluation will include the candidates' differentiation profile with respect to known checkpoints and their potential to serve either for monotherapy or in combination with other cancer treatments. This collaborative research will expand Compugen's ongoing assessment of the biology and mechanism of actions of its novel B7/CD28-like immune checkpoint proteins, and provide access to the world-class immuno-oncology research tools and expertise at Johns Hopkins University. The specific studies under the collaboration will assist Compugen in further substantiating the potential of its novel proteins as targets for cancer immunotherapy. It is anticipated that the results of this collaboration will significantly broaden the underlying scientific knowledge of Compugen's targets and will support their translation toward the clinic.
Johns Hopkins University School of Medicine Presents at Southeast BIO Investor & Partnering Forum, Nov-07-2013 08:30 AM
Nov 1 13
Johns Hopkins University School of Medicine Presents at Southeast BIO Investor & Partnering Forum, Nov-07-2013 08:30 AM. Venue: Jefferson Hotel, Richmond, Virginia, United States. Speakers: Elizabeth Good Mazhari.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries